Webinar title: Empowering the Community: Managing EVAF with ™Egrifta WR
A comprehensive, clinically grounded overview of excess visceral abdominal fat in people with HIV and the role of EGRIFTA WR™ in its management, focused on improving patient outcomes through education, early recognition, and targeted treatment strategies.
Speaker: Ms. Mable Taplin, RN, MSN
HIV Specialist at Theratechnologies, currently serving as Associate Director of Community Engagement.
Objectives:
By the end of this workshop, participants will be able to:
-
Build awareness of excess visceral abdominal fat (EVAF) and how it differs from general weight gain in people with HIV (PWH).
-
Understand how EVAF affects physical health, emotional well-being, and quality of life.
-
Explore tools and resources available to support PWH in managing EVAF.
-
Discover the therapeutic role of Egrifta WR in addressing EVAF.
Date: Thursday, 4th of June 2026
Time: 2 PM EST
Duration: 60 minutes